Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination With Pemetrexed (Alimta®) Versus Pemetrexed Alone in Patients With Locally-Advanced or Metastatic NSCLC
Vandetanib
D4200C00036
NCT00418886
Eudract2006-003695-35
Non-Small Cell Lung Cancer
Phase 3
 
Datasets and document are available as per Sanofi Policy and criteria
May 2017

Powered by ideaPoint, Inc.